Company profile for Algenex

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

VC-backed technology company developing and delivering disruptive technologies to boost recombinant biologics production using proprietary technologies based on Baculovirus vector expression systems (BVES) in insect cells. Supported by a first in class Strategic Advisory Board combining investment and operational experience in developing and leading companies in animal and human health. Two proprietary and patented technology ...
VC-backed technology company developing and delivering disruptive technologies to boost recombinant biologics production using proprietary technologies based on Baculovirus vector expression systems (BVES) in insect cells. Supported by a first in class Strategic Advisory Board combining investment and operational experience in developing and leading companies in animal and human health. Two proprietary and patented technology platforms, Top-Bac® and CrisBio®, to respond to industry’s challenges in the production of biologicals: development time, scalability, versatility and cost.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Ronda de Poniente, 14 Bajo ala izquierda, 28760 Tres Cantos, Madrid
Telephone
Telephone
+34 913 983 164
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Algenex Announces GMP Certification
Algenex Announces GMP Certification

19 Apr 2022

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2022/04/19/2424201/0/en/Algenex-Announces-GMP-Certification.html

GLOBENEWSWIRE
19 Apr 2022

https://www.globenewswire.com/news-release/2022/03/21/2406378/0/en/Algenex-Announces-Entry-into-the-Food-Technology-Market.html

GLOBENEWSWIRE
21 Mar 2022

https://www.algenex.com/algenex-y-werfen-renuevan-su-acuerdo-para-producir-test-de-diagnostico-humano-in-vitro-a-gran-escala/

PRESS RELEASE
18 Nov 2021

https://www.biospace.com/article/releases/algenex-and-biokit-renew-licensing-agreement-for-insect-based-production-of-human-in-vitro-diagnostics/?s=71

BIOSPACE
18 Nov 2021

https://www.algenex.com/algenex-mejor-compania-europea-en-animal-health-awards-2021/

PRESS RELEASE
10 Nov 2021

https://www.algenex.com/commercial-adoption-of-herdscreen-asfv-antibody-test-in-europe/

PRESS RELEASE
28 Oct 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty